Search
Close this search box.

News

Terumo acquires Aortica Corporation

Terumo Acquires Aortica Corporation to Support Continued Growth of Its Vascular Graft Business and Contribute to Personalised Aortic Therapy

Terumo Corporation (TSE: 4543) today announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy.

Aortica has developed an automated case planning software known as AortaFit™, designed to precisely match fenestrations on an endograft with the unique locations of each individual patient’s branch arteries during Fenestrated Endovascular Aortic Repair (FEVAR). The innovative technology is intended to improve graft anchoring while minimising the potential for endoleaks and migration that can result from the endovascular treatment of complex Abdominal Aortic Aneurysms (AAA).

The company has reported successful results for the first 30 patients undergoing FEVAR planned and performed using AortaFit™ as part of an FDA approved physician-sponsored investigational device exemption (IDE) study led by Benjamin Starnes, MD, Chief of Vascular Surgery, University of Washington. 100% of patients who had grafts planned by the automated software were successful including 16/30 treated with the TREO AAA stent-graft from Terumo Aortic.

Dr. Starnes commented: “Although several endografts are being studied under our protocol, the TREO abdominal aortic endograft has become our platform of choice because of its deliverability, conformability and graft design conducive to creating fenestrations. TREO is most likely to allow strut-free fenestrations in our series.”

Also in development is the BoulEVARd™ covered stent graft built specifically for FEVAR. The balloon expandable device has been designed to enable reliable engagement into the main body graft while improving conformability to the native artery.

Paul Holbrook, President of Terumo Aortic, said: “This acquisition is a tremendous opportunity for Terumo Aortic to expedite the development of a first-in-class, purpose-built FEVAR System, particularly in the United States. By leveraging the unique AortaFit System and BoulEVARd covered stent graft together with the proven capabilities of TREO, we aim to transform vascular disease management in this challenging patient population. Furthermore, we are convinced that the system helps us contribute to personalised therapy.”

Terumo will advance the development of the Aortica’s products, and then launch them in the U.S., Europe, Japan and other areas. The transaction is aimed to close within 2019 and will be funded through cash on hand. Terumo does not regard the impact of the acquisition on Terumo’s business performance of the fiscal year ending March 31, 2020 as significant.

Latest news

Contact us

Click the button below to get in touch. For more updates, follow us on X and LinkedIn. You can also view our VuMedi channel. 

Latest news

Subscribe for Email Updates

Your subscription could not be saved. Please try again.
Please check your email to confirm your subscription.

Subscribe to our regular email news to keep you updated on the latest information and events from Terumo Aortic.

We use Brevo as our marketing platform. By clicking below to submit this form, you acknowledge that the information you provided will be transferred to Brevo for processing in accordance with their terms of use

REGISTRATION FORM

AATS - Hands on Training - Registration

Personal Details

Thoraflex Hybrid Product Overview - Delivered Andrew Easton & Ryan Martin.

Sunday 28th April: 09:00 - 09:30
Session 1 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Adaptability & Versatility of Thoraflex Hybrid - Pedro Catarino, MD.

Sunday 28th April: 12:15 - 13:15
Session 2 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Thoraflex Hybrid Product Overview - Delivered Andrew Easton & Ryan Martin.

Sunday 28th April: 15:45 - 16:15
Session 3 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Thoraflex Hybrid Product Overview - Delivered Andrew Easton & Ryan Martin.

Monday 29th April: 09:15 - 09:45
Session 4 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Thoraflex Hybrid - The Canadian Experience - Michael Chu, MD.

Monday 29th April: 12:15 - 13:15
Session 5 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Disclaimer:
We collect your personal information for the sole purpose of managing event attendees and ensuring the smooth operation of the AATS event. Your data will not be used for marketing purposes unless you have explicitly signed up for updates or promotional materials.

REGISTRATION FORM

Charing Cross - Hands on Training - Registration

Personal Details

Fenestrated TREO Demo - Lukasz Siudmiak

Tuesday 23rd April: 10:30 - 11:30
Session 1 Checkbox
Spaces Remaining: 7

This session is now fully booked.

TREO Fit Mini-Symposia - Prof Vladimir Makaloski

Tuesday 23rd April: 13:30 - 14:30
Session 2 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Fenestrated TREO Mini Symposium - Prof Van Herwaarden

Tuesday 23rd April: 15:00 - 16:00
Session 3 Checkbox
Spaces Remaining: 8

This session is now fully booked.

RelayBranch Demo - Lukasz Siudmiak

Tuesday 23rd April: 16:30 - 17:30
Session 4 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Fenestrated TREO Demo - Lukasz Siudmiak

Wednesday 24th April: 10:30 - 11:30
Session 5 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Thoracoflo Mini Symposium - Prof Sabine Wipper

Wednesday 24th April: 13:30 - 14:30
Session 6 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Fenestrated TREO Demo - Lukasz Siudmiak

Wednesday 24th April: 15:00 - 16:00
Session 7 Checkbox
Spaces Remaining: 8

This session is now fully booked.

TEVAR Custom Made Demo - Lukasz Siudmiak

Wednesday 24th April: 16:30 - 17:30
Session 8 Checkbox
Spaces Remaining: 8

This session is now fully booked.

TEVAR Custom Made Demo - Lukasz Siudmiak

Thursday 25th April: 10:30 - 11:30
Session 9 Checkbox
Spaces Remaining: 8

This session is now fully booked.

Disclaimer:
We collect your personal information for the sole purpose of managing event attendees and ensuring the smooth operation of the AATS event. Your data will not be used for marketing purposes unless you have explicitly signed up for updates or promotional materials.